N-acetylcysteine and deferoxamine protect against acute renal failure induced by ischemia/reperfusion in rats

Revista Brasileira de Terapia Intensiva

Volumn 24, Issue 3, 2012, Pages 219-223

  Bernardi, Roberto Meister ^a   Constantino, Larissa ^a   MacHado, Roberta Albino ^a   Vuolo, Francieli ^a   Budni, Patricia ^a   Ritter, Cristiane ^a   Dal Pizzol, Felipe ^a  

^a UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

Author keywords

Acetylcysteine; Deferoxamine; Rats; Reactive oxygen species; Renal insufficiency; Reperfusion injury

Indexed keywords

EID: 84873892820     PISSN: 0103507X     EISSN: 19824335     Source Type: Journal    
DOI: 10.1590/S0103-507X2012000300003     Document Type: Article

References (42)

1. Biology of acute renal failure: therapeutic implications. Kidney Int. 1997;52(4):1102-15.
2. Thadhani R, Pascual M, Bonventre JV. Acute renal failure. N Engl J Med. 1996;334(22):1448-60. Review.
3. Meldrum DR, Cleveland JC Jr, Sheridan BC, Rowland RT, Banerjee A, Harken AH. Cardiac surgical implications of calcium dyshomeostasis in the heart. Ann Throrac Surg. 1996;61(4):1273-80.
4. Weight SC, Bell PR, Nicholson ML. Renal ischaemia-reperfusion injury. Br J Surg. 1996;83(2):162-70.
5. Rouslin W. Mitochondrial complexes I, II, III, IV, and V in myocardial ischemia and autolysis. Am J Physiol. 1983;244(6):H743-8.
6. Lauriat S, Linas SL. The role of neutrophils in acute renal failure. Semin Nephrol. 1998;18(5):498-504.
7. Paller MS, Jacob HS. Cytochrome P-450 mediates tissue-damaging hydroxyl radical formation during reoxygenation of the kidney. Proc Natl Acad Sci U S A. 1994;91(15):7002-6.
8. Halliwell B, Gutteridge JM. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol. 1990;186:1-85. Review.
9. Witko-Sarsat V, Rieu P, Descamps-Latscha B, Lesavre P, Halbwachs-Mecarelli L. Neutrophils: molecules, functions and pathophysiological aspects. Lab Invest. 2000;80(5):617-53.
10. Klebanoff SJ. Myeloperoxidase: friend and foe. J Leukoc Biol. 2005;77(5):598-625.
11. Erbas H, Aydogdu N, Kaymak K. Effects of N-acetylcysteine on arginase, ornithine and nitric oxide in renal ischemia-reperfusion injury. Pharmacol Res. 2004;50(5):523-7.
12. Huang H, He Z, Roberts LJ 2nd, Salahudeen AK. Deferoxamine reduces cold-ischemic renal injury in a syngeneic kidney transplant model. Am J Transplant. 2003;3(12):1531-7.
13. Spapen H. N-acetylcysteine in clinical sepsis: a difficult marriage. Crit Care. 2004;8(4):229-30.
14. Hsu BG, Lee RP, Yang FL, Harn HJ, Chen HI. Post-treatment with N-acetylcysteine ameliorates endotoxin shock-induced organ damage in conscious rats. Life Sci. 2006;79(21):2010-6.
15. Paterson RL, Galley HF, Webster NR. The effect of N-acetylcysteine on nuclear factor-kappa B activation, interleukin-6, interleukin-8, and intercellular adhesion molecule-1 expression in patients with sepsis. Crit Care Med. 2003;31(11):2574-8.
16. Wu ZL, Paller MS. Iron loading enhances susceptibility to renal ischemia in rats. Ren Fail. 1994;16(4):471-80.
17. Paller MS, Hedlund BE. Extracellular iron chelators protect kidney cells from hypoxia/reoxygenation. Free Radic Biol Med. 1994;17(6):597-603.
18. Baliga R, Zhang Z, Baliga M, Ueda N, Shah SV. In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity. Kidney Int. 1998;53(2):394-401.
19. de Vries B, Walter SJ, von Bonsdorff L, Wolfs TG, van Heurn LW, Parkkinen J, et al. Reduction of circulating redox-active iron by apotransferrin protects against renal ischemia-reperfusion injury. Transplantation. 2004;77(5):669-75.
20. Shah SV, Walker PD. Evidence suggesting a role for hydroxyl radical in glycerolinduced acute renal failure. Am J Physiol. 1988;255(3 Pt 2):F438-43.
21. Paller MS. Hemoglobin-and myoglobin-induced acute renal failure in rats: role of iron in nephrotoxicity. Am J Physiol. 1988;255(3 Pt 2):F539-44.
22. Klebanoff SJ, Wallersdorph AM, Michel BR, Rosen H. Oxygen-based free radical generation by ferrous ions and deferoxamine. J Biol Chem. 1989;264(33):19765-71.
23. Zager RA, Foerder CA. Effects of inorganic iron and myoglobin on in vitro proximal tubular lipid peroxidation and cytotoxicity. J Clin Invest. 1992;89(3):989-95.
24. Ritter C, Andrades ME, Reinke A, Menna-Barreto S, Moreira JC, Dal-Pizzol F. Treatment with N-acetylcysteine plus deferoxamine protects rats against oxidative stress and improves survival in sepsis. Crit Care Med. 2004;32(2):342-9.
25. Liaudet L, Mabley JG, Soriano FG, Pacher P, Marton A, Hasko G, et al. Inosine reduces systemic inflammation and improves survival in septic shock induced by cecal ligation and puncture. Am J Respir Crit Care Med. 2001;164(7):1213-20.
26. Draper HH, Hadley M. Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol. 1990;186:421-31.
27. Levine RL, Williams JA, Stadtman ER, Shacter E. Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol. 1994;233:346-57.
28. Maruyama Y, Lindholm B, Stenvinkel P. Inflammation and oxidative stress in ESRD-the role of myeloperoxidase. J Nephrol. 2004;17 Suppl 8:S72-6.
29. Gonzalez-Flecha B, Boveris A. Mitochondrial sites of hydrogen peroxide production in reperfused rat kidney cortex. Biochim Biophys Acta. 1995;1243(3):361-6.
30. Zulueta JJ, Sawhney R, Yu FS, Cote CC, Hassoun PM. Intracellular generation of reactive oxygen species in endothelial cells exposed to anoxia-reoxygenation. Am J Physiol. 1997;272(5 Pt 1):L897-902.
31. McKelvey TG, Hollwarth ME, Granger DN, Engerson TD, Landler U, Jones HP. Mechanisms of conversion of xanthine dehydrogenase to xanthine oxidase in ischemic rat liver and kidney. Am J Physiol. 1988;254(5 Pt 1):G753-60.
32. Linas SL, Whittenburg D, Repine JE. Role of xanthine oxidase in ischemia/reperfusion injury. Am J Physiol. 1990;258(3 Pt 2):F711-6.
33. Greene EL, Paller MS. Xanthine oxidase produces O2-. in posthypoxic injury of renal epithelial cells. Am J Physiol. 1992;263(2 Pt 2):F251-5.
34. Granger DN. Role of xanthine oxidase and granulocytes in ischemiareperfusion injury. Am J Physiol. 1988;255(6 Pt 2):H1269-75. Review.
35. Kooij A, Schijns M, Frederiks WM, Van Noorden CJ, James J. Distribution of xanthine oxidoreductase activity in human tissues-a histochemical and biochemical study. Virchows Arch B Cell Pathol Incl Mol Pathol. 1992;63(1):17-23.
36. Linder N, Rapola J, Raivio KO. Cellular expression of xanthine oxidoreductase protein in normal human tissues. Lab Invest. 1999;79(8):967-74.
37. Shokeir AA, Barakat N, Hussein AA, Awadalla A, Abdel-Aziz A, Abo-Elenin H. Role of combination of L-arginine and -tocopherol in renal transplantation ischaemia/reperfusion injury: a randomized controlled experimental study in a rat model. BJU Int. 2011;108(4):612-8.
38. Kizilgun M, Poyrazoglu Y, Oztas Y, Yaman H, Cakir E, Cayci T, et al. Beneficial effects of N-acetylcysteine and ebselen on renal ischemia/reperfusion injury. Ren Fail. 2011;33(5):512-7.
39. Yurdakul T, Kulaksizoglu H, Pikin MM, Avunduk MC, Ertemli E, Gokce G, et al. Combination antioxidant effect of -tocoferol and erdosteine in ischemiareperfusion injury in rat model. Int Urol Nephrol. 2010;42(3):647-55. Erratum in Int Urol Nephrol. 2010;42(3):657. Gokce, Gurhan [added].
40. Ritter C, Cunha AA, Echer IC, Andrades M, Reinke A, Lucchiari N, et al. Effects of N-acetylcysteine plus deferoxamine in lipopolysaccharideinduced acute lung injury in the rat. Crit Care Med. 2006;34(2):471-7.
41. Petronilho F, Constantino L, de Souza B, Reinke A, Martins MR, Fraga CM, et al. Efficacy of the combination of N-acetylcysteine and deferoxamine in the prevention and treatment of gentamicin-induced acute renal failure in male Wistar rats. Nephrol Dial Transplant. 2009;24(7):2077-82.
42. Fraga CM, Tomasi CD, Biff D, Topanotti MF, Felisberto F, Vuolo F, et al. The effects of N-acetylcysteine and deferoxamine on plasma cytokine and oxidative damage parameters in critically ill patients with prolonged hypotension: a randomized controlled trial. J Clin Pharmacol. 2012;52(9):1365-72.